Antimicrobial resistance in non-typhoidal salmonellas from humans in Northern Ireland, 2001-2003: Standardization needed for better epidemiological monitoring

Epidemiology and Infection

Volumn 135, Issue 4, 2007, Pages 675-680

  Ong, Grace ^a   Wilson, I ^b   Smyth, B ^b   Rooney, P ^b  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; FURAZOLIDONE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; STREPTOMYCIN; SULFAMETHOXAZOLE; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DRUG TREATMENT FAILURE; EPIDEMIC; EPIDEMIOLOGICAL DATA; HUMAN; IRELAND; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RELIABILITY; RETROSPECTIVE STUDY; SALMONELLA; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SENSITIVITY ANALYSIS; STANDARDIZATION;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; MALE; NORTHERN IRELAND; SALMONELLA; SALMONELLA INFECTIONS;

EID: 34247468928     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806007291     Document Type: Article

References (28)

1. Threlfall EJ. Antimicrobial drug resistance in Salmonella: problems and perspectives in food- and water-borne infections. FEMS Microbiology Reviews 2002; 26: 141-148.
2. Department for Environment Food and Rural Affairs. Zoonoses report United Kingdom 2004. London: Department for Environment Food and Rural Affairs, 2005 (www.defra.gov.uk/animalh/diseases/zoonoses/ zoonoses_reports/zoonoses2004.pdf). Accessed 9 August 2005.
3. Anon. Salmonella Enteritidis non-Phage Type 4 infections England and Wales: 2000 to 2004 - report from a multi-agency outbreak control team. Communicable Disease Report Weekly 2004; 14: 2-6.
4. Threlfall EJ. Epidemic Salmonella typhimurium DT104 - a truly international multiresistant clone. Journal of Antimicrobial Chemotherapy 2000; 46: 7-10.
5. Smyth B (ed.). Communicable Diseases: Provisional Summary 2003, Northern Ireland edition. Health Protection Agency, London, UK. 2004 (http://www.cdscni.org.uk/publications/AnnualReports/ Review%20of%20Communicable%20Diseases.asp). Accessed 9 August 2005.
6. Fisher IST. International trends in Salmonella serotypes 1998-2003 - a surveillance report from the Enter-net international surveillance network. Eurosurveillance 2004; 9: 45-47.
7. Smyth B (ed.). Foodborne and gastrointestinal infections during 2004. Communicable Disease Monthly Report Northern Ireland Edition 2005: 14: 2-5.
8. Chief Medical Officer. Getting Ahead of the Curve: A strategy for combating infectious diseases (including other aspects of health protection). London: Department of Health, 2002 (http://www.dh.gov.uk/ PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/ PublicationsPolicyAndGuidanceArticle/fs/ en?CONTENT_ID=4007697&chk=t0v3Uu). Accessed 9 August 2005.
9. Webb CH (chairman). Antimicrobial Resistance Action Plan 2002-5. Belfast: Department of Health, Social Services and Public Safety, 2002 (www.dhsspsni.gov.uk/phealth/docs/AMRAP02-05.pdf). Accessed 9 August 2005.
10. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests, 6th edn. Approved Standard M2-A6. Villanova, PA: NCCLS, 1997.
11. Andrews JM. BSAC standardised disc susceptibility testing method (version 3). Journal of Antimicrobial Chemotherapy 2004; 53: 713-728.
12. Department for Environment Food and Rural Affairs. Zoonoses Report United Kingdom 2002. London: Department for Environment Food and Rural Affairs, 2004 (http://www.defra.gov.uk/animalh/diseases/zoonoses/ reports.htm). Accessed 9 August 2005.
13. Anon. National Disease Surveillance Centre Annual Report 2003 (http://www.ndsc.ie/hpsc/AboutHPSC/AnnualReports/File,952,en.pdf). Accessed 4 July 2006.
14. Threlfall EJ, et al. Antimicrobial drug resistance in non-typhoidal salmonellas from humans in England and Wales in 1999: decrease in multiple resistance in Salmonella enterica serotypes Typhimurium, Virchow, and Hadar. Microbial Drug Resistance 2000; 6: 319-325.
15. Helms M, et al. International Salmonella Typhimurium DT104 infections, 1992-2001. Emerging Infectious Diseases 2005; 11: 859-867.
16. Fluit AC. Towards a more virulent and antibiotic-resistant Salmonella? FEMS Immunology and Medical Microbiology 2005; 43: 1-11.
17. Varma JK, et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. Journal of Infectious Diseases 2005; 191: 554-561.
18. Varma JK, et al. Hospitalization and antimicrobial resistance in Salmonella outbreaks, United States, 1984-2002. Emerging Infectious Diseases 2005; 11: 943-946.
19. Threlfall J, Hopkins KL, Ward LR. Diversification in Salmonella Typhimurium DT104. Emerging Infectious Diseases 2005; 11: 980-981.
20. Aarestrup FM, et al. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrobial Agents and Chemotherapy 2003; 47: 827-829.
21. Prendiville P, et al. Antimicrobial resistance in 2000 (England and Wales). Communicable Disease Surveillance Centre 2001, pp. 1-46. (http://www.hpa.org.uk/infections/topics_az/ antimicrobial_resistance/amr.pdf). Accessed 9 August 2005.
22. Crawford LM. Withdrawal of approval of the new animal drug application for enrofloxacin in poultry. Final decision of the commissioner. Docket number 2000N-1571. Washington: Department of Health and Human Services, US Food and Drug Administration, 2005 (http://www.fda.gov/cvm/FQWithdrawal.html). Accessed 9 August 2005.
23. Gill N, Reilly W, Smith, H. Enter-net quarterly Salmonella reports. (http://www.hpa.org.uk/hpa/inter/enter-net_reports.htm). Accessed 9 August 2005.
24. Threlfall EJ, et al. Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: Results of international multi-centre surveillance. Eurosurveillance 2003; 8: 41-45.
25. Mølbak K, Gerner-Smidt P, Wegener HC. Increasing quinolone resistance in Salmonella enterica serotype Enteritidis. Emerging Infectious Diseases 2002; 8: 514-515.
26. Threlfall EJ, et al. Resistance to ceftriaxone and cefotaxime in non-typhoidal Salmonella enterica in England and Wales, 1998-99. Journal of Antimicrobial Chemotherapy 2000; 46: 60-862.
27. Anon. Outbreak of multidrug-resistant Salmonella Newport, United States, January-April 2002. Morbidity and Mortality Weekly Report 2002; 51: 545-548.
28. Wilson IG, Whitehead E. Emergence of Salmonella Blockley, possible association with long-term reactive arthritis, and antimicrobial resistance. FEMS Immunology and Medical Microbiology 2006, 46: 3-7.